RHUMBLINE ADVISERS - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$282,649
-76.1%
83,136
-48.3%
0.00%
-100.0%
Q2 2023$1,181,600
+71904.9%
160,762
+1.5%
0.00%
-50.0%
Q1 2023$1,641
-8.1%
158,356
+4.8%
0.00%0.0%
Q4 2022$1,785
-99.9%
151,165
+0.3%
0.00%
-60.0%
Q3 2022$3,164,000
-30.0%
150,726
+3.5%
0.01%
-28.6%
Q2 2022$4,519,000
-22.9%
145,600
+2.1%
0.01%
-12.5%
Q1 2022$5,858,000
-4.5%
142,666
+1.1%
0.01%0.0%
Q4 2021$6,136,000
-17.8%
141,151
-5.3%
0.01%
-20.0%
Q3 2021$7,461,000
-18.1%
149,003
+3.0%
0.01%
-16.7%
Q2 2021$9,113,000
-20.9%
144,670
+16.6%
0.01%
-25.0%
Q1 2021$11,526,000
-1.2%
124,053
-4.7%
0.02%0.0%
Q4 2020$11,665,000
-11.0%
130,189
+2.6%
0.02%
-23.8%
Q3 2020$13,112,000
+18.5%
126,899
-9.3%
0.02%
+16.7%
Q2 2020$11,064,000
+30.5%
139,912
-4.5%
0.02%0.0%
Q1 2020$8,477,000
+7.9%
146,514
+0.6%
0.02%
+38.5%
Q4 2019$7,856,000
+9.9%
145,609
+6.4%
0.01%0.0%
Q3 2019$7,151,000
+8.8%
136,787
+0.6%
0.01%
+8.3%
Q2 2019$6,571,000
-1.4%
136,012
+3.1%
0.01%
-7.7%
Q1 2019$6,663,000
-12.7%
131,886
+2.4%
0.01%
-23.5%
Q4 2018$7,633,000
+11.1%
128,755
+23.3%
0.02%
+30.8%
Q3 2018$6,873,000
+42.4%
104,401
+9.3%
0.01%
+30.0%
Q2 2018$4,825,000
+9.5%
95,557
+14.2%
0.01%
+11.1%
Q1 2018$4,406,000
+15.3%
83,680
+1.8%
0.01%
+12.5%
Q4 2017$3,821,000
+33.4%
82,228
+16.1%
0.01%
+33.3%
Q3 2017$2,865,000
+22.4%
70,829
+2.6%
0.01%
+20.0%
Q2 2017$2,340,000
+19.0%
69,004
+1.9%
0.01%0.0%
Q1 2017$1,967,000
+23.6%
67,742
+39.7%
0.01%
+25.0%
Q4 2016$1,592,000
+8.7%
48,489
+4.4%
0.00%0.0%
Q3 2016$1,465,000
+23.2%
46,455
+9.8%
0.00%0.0%
Q2 2016$1,189,000
-24.0%
42,292
-1.7%
0.00%
-20.0%
Q1 2016$1,564,000
-6.7%
43,024
+2.7%
0.01%0.0%
Q4 2015$1,676,000
+49.4%
41,899
+6.4%
0.01%
+25.0%
Q3 2015$1,122,000
-10.2%
39,394
+3.8%
0.00%0.0%
Q2 2015$1,250,000
-2.1%
37,936
-14.6%
0.00%0.0%
Q1 2015$1,277,000
+5.5%
44,411
-0.1%
0.00%0.0%
Q4 2014$1,211,000
+34.0%
44,461
+4.8%
0.00%
+33.3%
Q3 2014$904,000
-4.7%
42,436
+0.5%
0.00%0.0%
Q2 2014$949,000
-8.3%
42,236
+3.1%
0.00%0.0%
Q1 2014$1,035,000
+7.0%
40,968
-2.6%
0.00%0.0%
Q4 2013$967,000
+15.5%
42,058
-4.3%
0.00%0.0%
Q3 2013$837,000
+32.0%
43,958
+0.0%
0.00%
+50.0%
Q2 2013$634,00043,9560.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders